Neuronetics To Present Clinical Data at The American Psychiatric Association 2021 Annual Meeting
MALVERN, Pa., April 29, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, announced today it will present clinical data in virtual poster sessions as part of the American Psychiatric Association’s Annual Meeting virtual programming.
The American Psychiatric Association is the leading professional psychiatric organization in the U.S. and is hosting virtual events this year May 1-3 in place of its traditional Annual Meeting, giving attendees a chance to experience sessions remotely. Neuronetics is a Gold sponsor of the event and will host two poster presentations on the company’s latest research with NeuroStar Advanced Therapy for Mental Health in patients with Major Depressive Disorder (MDD).
On Monday, May 3, Neuronetics will present real-world clinical data, addressing the following topics:
Neuronetics will also host a virtual exhibit booth at the event, offering attendees the opportunity to learn more about the NeuroStar Advanced Therapy for Mental Health treatment for MDD and its 5 STARS to Success Program for NeuroStar practices. Plan to visit and connect with someone from Neuronetics at the booth located within the “Virtual Exhibit Gallery” of the APA virtual meeting portal.
With 3.5 million treatments delivered across over 900 practice locations in the United States, Neuronetics continues to be a depression treatment industry leader. For more information, visit www.neurostar.com.
Shadow IT â€“ Why You Need to Eliminate It and How
Exhibit Hall Open
Engineering AIOps Sales Success